Trademark Search in Canada

PATRYS

View On IC.GC.CA

REGISTERED

on 1 Jun 2009

Last Applicant/ Owned by

Patrys Limited

Level 6, Suite 614343 Little Collins StreetMelbourne VIC 3000

Serial Number

1351205 filed on 12^th Jun 2007

Registration Number

TMA741177 registered on 1^st Jun 2009

Registration expiry Date

1^st Jun 2034

Correspondent Address

WENDY D. RIEL

(RIEL PROFESSIONAL CORPORATION)411 Roosevelt Avenue, Suite 206Ottawa

ONTARIO

K2A3X9

PATRYS

Trademark usage description

pharmaceutical and biotechnology preparations and substances namely, monoclonal antibodies, taggedantibodies, other proteins and antibody based produc Read More

Classification Information

Class [005]
Pharmaceutical and biotechnology preparations and substances namely, monoclonal antibodies, taggedantibodies, other proteins and antibody based products, for human medicinal purposes, namely thetreatment of cancers and autoimmune diseases; veterinary preparations and substances namely, monoclonalantibodies, tagged antibodies, other proteins and antibody based products, for human medicinal purposes;diagnostic preparations and reagents for medical purposes; antibodies, antibody fragments; anti-bodyconjugates; preparations for the treatment, reconstruction and repair of antibodies; immunological antibodiesfor medical use; monoclonal antibodies for diagnostic use (medical); monoclonal antibodies for medical use;monoclonal antibodies for therapeutic purposes; products containing antibodies for use in medicine namely,monoclonal antibodies, tagged antibodies, other proteins and antibody based products, for human medicinalpurposes, namely the treatment of cancers and autoimmune diseases; proteins for medical use in bindingantibodies; proteins for medical use in detecting antibodies; reagents for use in the development ofmonoclonal antibodies (for medical purposes); molecular targets and associated information for drug andvaccine development; reagents for use in the development of monoclonal antibodies (for veterinarypurposes); tagged antibodies for medical use; vaccines; vaccines against cancer viral or bacterial infection;vaccines for human use; vaccine adjuvants; diagnostic preparations and reagents for the diagnosis of humanphysiological conditions, namely diseases, namely, cancer and autoimmune diseases; antibodies; antibodyfragments; antibody conjugates; preparations for the treatment, reconstruction and repair of antibodies;antibodies, comprising monoclonal antibodies for the diagnosis and/or prognosis of human and/or animalphysiological conditions, namely diseases, namely, cancer and autoimmune diseases; proteins for medicaluse in detecting antibodies; reagents for use in the development of monoclonal antibodies, reagents,substances, products and testing materials for medical purposes namely, reagents for use in tests for thediagnosis and/or prognosis of human and/or animal physiological conditions, namely diseases, namely,cancer and autoimmune diseases; reagents for use in diagnostic tests (for medical purposes); reagents formedical research applications (for diagnosis); recombinant human protein production cell line; proteins formedical use in recombinant DNA technology; biological reagents for use in molecular biology.

Classification kind code

Class [042]
Scientific research, clinical research, development, advisory and consultancy services in relation to antibody production; drug discovery namely, identifying, discovering, performing research on and developing new drugs for the treatment of cancers and autoimmune diseases; vaccine screening; advisory services relating to diagnostic products; diagnostic testing services; medical research services; scientific research for medical purposes; pharmaceutical research services; diagnostic and research services and screening; preparation of reports relating to medical, scientific and technical research; provision of information relating to medical, scientific and technical research licensing of research and development; research and development of medical and pharmaceutical products namely, drugs and therapeutics for the diagnosis and treatment of cancers and autoimmune diseases; laboratory research; laboratory services (scientific research or analysis); analysis of tissues for medical research; antibody generation services; molecular target discovery and development.

Classification kind code

Mark Details

Serial Number

1351205

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 50 on 24^th Apr 2009	Allowed
Submitted for opposition 51 on 24^th Apr 2009	Allowance Notice Sent
Submitted for opposition 42 on 7^th Jan 2009	Advertised
Submitted for opposition 26 on 24^th Dec 2008	Approved
Submitted for opposition 27 on 5^th Nov 2008	Approval Notice Sent
Submitted for opposition 22 on 17^th Apr 2008	Search Recorded
Submitted for opposition 20 on 17^th Apr 2008	Examiner's First Report
Submitted for opposition 31 on 19^th Jun 2007	Formalized
Submitted for opposition 30 on 12^th Jun 2007	Filed
Submitted for opposition 1 on 12^th Jun 2007	Created